Healthcare

Space Strategies 2022

October 24-25, 2022
Austin, TX

At this conference, you’ll get the critical space planning data, metrics, processes, and solutions that you’ll need to meet your goals for successful hybrid and digital workplace initiatives, higher space utilization, data collection and reporting, multi-purpose spaces and increased flexibility, improved space allocation processes, better workplace engagement and experience, lower occupancy cost, and increased organizational performance.

Hospital Facility Resiliency Planning for the Next Pandemic

Lessons Learned from COVID-19

Published 3-31-2021

A public hospital in the Midwest was in the process of designing a new 12-story high-acuity ICU tower when the COVID-19 pandemic struck. They witnessed their colleagues in hospitals across the country struggling to accommodate the surge of patients who needed isolation units in facilities that were not designed for them, forcing them to shutter the revenue-generating general medicine practice in the rest of the hospital. So the Midwest hospital pivoted. They reassessed design options for the top two floors to serve as dedicated isolation/surge floors, when needed, without disrupting the operations in the rest of the building.

Life Sciences Sector Experiencing Era of Unprecedented Growth

Converging Technologies, Increased Funding, and Pandemic-Related Market Disruptions Drive Nationwide Demand for Life Science Space

Published 2-17-2021

The life sciences sector is experiencing an era of unprecedented growth driven by a surge in both public and private funding combined with a post-pandemic sense of urgency and market opportunity. According to a report released by Newmark in January 2021, more than 36 million sf of new construction is expected to be delivered in the nation’s top 14 life science markets, as life science investments more than triple. While demand for life science and biotech facilities has been growing steadily over the past decade, the COVID-19 crisis heightened national awareness around the need for increased research, diagnostic, and domestic manufacturing capabilities. Investors are also seeing significant potential in the future of personalized medicine, genomics, and other life science-related fields, as emerging technologies and research disciplines converge.